Do Hackwon, Kim Soo Jin, Lee Chang Woo, Kim Han-Woo, Park Hyun Ho, Kim Ho Min, Park Hyun, Park HaJeung, Lee Jun Hyuck
Division of Polar Life Sciences, Korea Polar Research Institute, Incheon 406-840, Republic of Korea.
Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 305-701, Republic of Korea.
Sci Rep. 2015 Feb 3;5:8196. doi: 10.1038/srep08196.
The ubiX gene of Colwellia psychrerythraea strain 34H encodes a 3-octaprenyl-4-hydroxybenzoate carboxylase (CpsUbiX, UniProtKB code: Q489U8) that is involved in the third step of the ubiquinone biosynthesis pathway and harbors a flavin mononucleotide (FMN) as a potential cofactor. Here, we report the crystal structures of two forms of CpsUbiX: an FMN-bound wild type form and an FMN-unbound V47S mutant form. CpsUbiX is a dodecameric enzyme, and each monomer possesses a typical Rossmann-fold structure. The FMN-binding domain of UbiX is composed of three neighboring subunits. The highly conserved Gly15, Ser41, Val47, and Tyr171 residues play important roles in FMN binding. Structural comparison of the FMN-bound wild type form with the FMN-free form reveals a significant conformational difference in the C-terminal loop region (comprising residues 170-176 and 195-206). Subsequent computational modeling and liposome binding assay both suggest that the conformational flexibility observed in the C-terminal loops plays an important role in substrate and lipid bindings. The crystal structures presented in this work provide structural framework and insights into the catalytic mechanism of CpsUbiX.
嗜冷红杆菌34H菌株的ubiX基因编码一种3 - 辛基 - 4 - 羟基苯甲酸羧化酶(CpsUbiX,UniProtKB编码:Q489U8),该酶参与泛醌生物合成途径的第三步,并含有黄素单核苷酸(FMN)作为潜在的辅因子。在此,我们报道了两种形式的CpsUbiX的晶体结构:一种结合FMN的野生型形式和一种未结合FMN的V47S突变体形式。CpsUbiX是一种十二聚体酶,每个单体具有典型的罗斯曼折叠结构。UbiX的FMN结合结构域由三个相邻亚基组成。高度保守的Gly15、Ser41、Val47和Tyr171残基在FMN结合中起重要作用。结合FMN的野生型形式与未结合FMN的形式的结构比较揭示了C末端环区域(包含残基170 - 176和195 - 206)存在显著的构象差异。随后的计算建模和脂质体结合试验均表明,在C末端环中观察到的构象灵活性在底物和脂质结合中起重要作用。这项工作中呈现的晶体结构为CpsUbiX的催化机制提供了结构框架和见解。